All In MedTech

FDA Clearance Tracker · P140031-S052

Sapien 3 Transcatheter Heart Valve

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 28, 2017 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Sep 28, 2017

Approved

Time to decision

36 days

Received Aug 23, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P140031-S052
Device name
Sapien 3 Transcatheter Heart Valve
Applicant location
Irvine, CA
Received
Aug 23, 2017
Decided
Sep 28, 2017
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P140031

Device type

Device class
Class III

Every decision under product code NPT

FDA's approval statement

As written in FDA's record.

Approval for updates to the labeling to include instructions for implantation using the subclavian and axillary access approaches.

Source documents

Other decisions for Edwards Lifesciences, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.